Inovio Pharmaceuticals, Inc. announced the appointment of Jay Shepard to its Board of Directors. Mr. Shepard brings broad healthcare and financial experience to the board given his tenure as CEO of several biotech companies, his multiple corporate board appointments and his expertise as a healthcare venture capitalist. Mr. Shepard was an Executive Partner at Sofinnova. Inovio also announced the retirement of Mort Collins from its Board. Dr. Collins had been a founding Board member of Inovio's predecessor, VGX Pharmaceuticals. Mr. Shepard is currently Non-executive Chairman and formerly President and Chief Executive Officer of Aravive.